ACIRNA Therapeutics is developing the next advance in RNA medicine. Building on our foundation in self-amplifying RNA, we have invented amplified circular RNA (acRNA) — a new RNA technology that unites amplification and circularization in a single platform, opening new possibilities for precision RNA programming and the development of transformative therapies across indications. We are advancing first- and best-in-class RNA therapeutics engineered to reprogram the immune system against cancer and autoimmune disease. Amplified + Circular + RNA → ACIRNA. Immunity Amplified. Formerly Chimeron Bio.
| Website | http://acirna.com |
| Employees | 13 (6 on RocketReach) |
| Founded | 2015 |
| Address | 601 Walnut Street Suite 825, Philadelphia, Pennsylvania 19106, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+16 more
(view full list)
|
| Industry | Biotechnology Research, Biotechnology, Science and Engineering, Health Care, Therapeutics |
| Keywords | Cancer Treatment, Biotechnology, Mrna Therapeutics, Nanoparticle Drug Delivery, Tumor Microenvironment, Gene Therapy, Oncology, Precision Medicine, Targeted Therapy, Breakthrough Therapies, Drug Development, Immunotherapy, Novel Therapeutics, Biopharma, Pharmaceutical, Molecular Medicine, Biotech Research, Clinical Trials |
Looking for a particular Chimeron Bio employee's phone or email?
Kevin Heyeck is the CEO and Director of Chimeron Bio.
6 people are employed at Chimeron Bio.
Chimeron Bio is based in Philadelphia, Pennsylvania.